MRI IMAGING Clinical Trials

17 clinical trials for MRI IMAGING across international registries, including 7 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Low-Field MRI in Stroke Code Patients — RECRUITING
• THE CANADIAN LUNG OUTCOMES IN USERS OF VAPING DEVICES (CLOUD) STUDY — RECRUITING
• DEVELOPMENT OF HARDWARE AND SOFTWARE FOR PULMONARY MAGNETIC RESONANCE IMAGING USING INHALED TRACER GASES — RECRUITING
• CANADIAN LONGITUDINAL STUDY OF LUNG STRUCTURE AND FUNCTION IN CANNABIS SMOKERS (CANUCK) — RECRUITING
• A MECHANISTIC PILOT OPEN-LABEL STUDY TO EVALUATE THE EFFECT OF BENRALIZUMAB ON AIRWAY FUNCTION AND INFLAMMATION IN PATIENTS WITH SEVERE, POORLY-CONTROLLED EOSINOPHILIC ASTHMA USING INHALED HYPERPOLARIZED 129XE MRI (AERFLO) — RECRUITING
• NON-ISOTOPE BASED IMAGING MODALITIES VS 99MTC SPECT MYOCARDIAL PERFUSION IMAGING (MPI) TO DETECT MYOCARDIAL ISCHEMIA IN PATIENTS AT HIGH RISK FOR ISCHEMIC CARDIOVASCULAR EVENTS — RECRUITING
• STRUCTURE AND FUNCTION MRI OF ASTHMA — RECRUITING
• Phase Resolved Functional Lung MRI and Oscillometry for the Observation of Healthy Lung Function — NOT_YET_RECRUITING
• The MagnaSafe-2 Registry: Assessing the Risks of Magnetic Resonance Imaging in Three Patient Groups — NOT_YET_RECRUITING
• Mechanistic Study of SPARC-Mediated Regulation of Neutrophil Extracellular Trap Formation in the Brain Metastatic Microenvironment of Breast Cancer — ACTIVE_NOT_RECRUITING
• An MRI Ancillary Study of a Malaria Fever Investigation — COMPLETED
• Assessment of Investigational Magnetic Resonance Imaging and Post-Processing Procedures — OTHER · NA
• A MULTICENTER, RANDOMIZED, PROSPECTIVE DOUBLE-BLIND, CROSS OVER PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF 0.04 MMOL GD/KG BODY WEIGHT OF GADOQUATRANE FOR MRI IN ADULTS WITH KNOWN OR SUSPECTED PATHOLOGY OF THE CENTRAL NERVOUS SYSTEM (CNS), COMPARED TO 0.1 MMOL GD/KG APPROVED MACROCYCLIC GADOLINIUM-BASED CONTRAST AGENTS (GBCAS) — COMPLETED · PHASE3
• A MULTICENTER, PROSPECTIVE, OPEN-LABEL STUDY TO EVALUATE THE PHARMACOKINETICS AND SAFETY OF GADOQUATRANE IN PEDIATRIC PARTICIPANTS (FROM BIRTH TO <18 YEARS) UNDERGOING CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING (CE-MRI). — COMPLETED
• A MULTICENTER, RANDOMIZED, PROSPECTIVE DOUBLE-BLIND, CROSS OVER PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF 0.04 MMOL GD/KG BODY WEIGHT OF GADOQUATRANE FOR MRI IN ADULTS WITH KNOWN OR SUSPECTED PATHOLOGY OF ANY BODY REGION (EXCEPT CNS), COMPARED TO 0.1 MMOL GD/KG APPROVED MACROCYCLIC GADOLINIUM-BASED CONTRAST AGENTS (GBCAS) — COMPLETED · PHASE3
• MULTIPARAMETRIC MRI FOR PROSTATE CANCER LOCALIZATION AND CHARACTERIZATION USING HYPERPOLARIZED PYRUVATE (13C) INJECTION — COMPLETED
• COMPARISON OF THE EFFECTS OF A SMALL PARTICLE CORTICOSTEROID, ALVESCO®, TO A LARGER PARTICLE CORTICOSTEROID ON THE SMALL AIRWAY PHYSIOLOGY OF ASTHMATIC SUBJECTS BY HYPERPOLARIZED HELIUM-3 MRI — NOT_YET_RECRUITING

Refine this search